BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Feature

Navigating European Regulatory and Market Access Pathways: Crucial Considerations from TMC’s Catherine Moncad

As more APAC biotech and pharma companies look to Europe for regulatory approval and commercialisation, navigating complex EU and UK requirements early is ...

January 19, 2026 | News

Leading the Future of Care: Patient Organizations Driving Health System Transformation

Real Change Starts with Listening Across the Asia Pacific, Middle East, and Africa, healthcare systems are facing mounting pressures with rising rates of ...

January 05, 2026 | Opinion | By Sung Lee, Executive Director, Region Communications and Patient Advocacy, Asia Pacific, Middle East, Africa (APMA), Novartis

How Asia Pacific Is Forcing A Rethink On Surgical Outcomes Measurement

As surgical volumes rise and care pathways grow more complex across Asia Pacific, the limitations of how post operative outcomes are measured are becoming ...

January 05, 2026 | Expert Insight | By editor@biopharmaapac.com

2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know

At the centre of this momentum stood the U.S. Food and Drug Administration, whose 2025 approvals illustrated how medicine is moving decisiv...

December 29, 2025 | Analysis | By arcilla.fran@biopharmaapac.com

BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025

The year 2025 has marked a pivotal moment for the biopharmaceutical industry as it reckons with the aftershocks of a global pandemic and ongoing geopolitic...

December 24, 2025 | Analysis

How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026

Health systems have become more consolidated. Some are acting as both providers and payers, and therefore have more influence as gatekeepers of market acce...

December 10, 2025 | Report

Bringing Multi-Modal Intelligence to Early Clinical Recruitment

A protocol might specify a cohort defined by inflammatory markers, disease severity, a diagnostic pattern or a particular biological signature — but ...

December 10, 2025 | News | By Tom Stubbs, PHD – CEO of Hurdle.bio

Building Trust Through Quality: How QMS Powers Manufacturing Excellence in Life Sciences

Life sciences sector, a robust Quality Management System (QMS) has become the cornerstone of manufacturing excellence. This is especially true for the medi...

October 16, 2025 | Analysis

Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems

Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...

October 15, 2025 | Interview

Anthony Elgamal: Redefining First-Line Treatment in EGFR-Mutated Lung Cancer

BioPharma APAC speaks with Anthony Elgamal, Vice President of Oncology, Johnson & Johnson Innovative Medicine Asia Pacific, on th...

October 13, 2025 | Expert Insight

Turning Signals into Cures: The Big Data Blueprint for Cell Therapy Factories

Cell therapy manufacturing is entering a data-driven era, as the industry grapples with complex production processes, high costs, and the need for personal...

October 07, 2025 | Analysis

Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate Cell and Gene Therapy Access Between Japan and Australia

As the cell and gene therapy (CGT) sector moves from scientific promise to large-scale reality, collaboration between nations with strong translational and...

October 06, 2025 | News | By arcilla.fran@biopharmaapac.com

Redefining Cancer Care in Southeast Asia: Siemens Healthineers’ Fabrice Leguet on Turning Awareness into Action

Cancer care in Southeast Asia stands at a critical crossroads. While awareness of early detection is high, the translation into meaningful action remains p...

October 01, 2025 | Interaction | By arcilla.fran@biopharmaapac.com

The State of Biotech and Life Science Jobs in Asia Pacific – 2025

In 2025, Asia-Pacific has emerged as the fastest-growing hub for biotech and life sciences employment, fuelled by a powerful combination of government supp...

September 09, 2025 | Report

Stay Connected